G-417 Comparative Safety of Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT2i) and Dipeptidyl Peptidase-4 Inhibitors (DPP4i) in Patients Receiving Anti-Neoplastic Therapies for Cancer